Loading…

Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis

Neuro-ophthalmologic manifestations are uncommon in sarcoidosis. We aim to assess the prognostic factors and outcome of neuro-ophthalmic sarcoidosis. We conducted a multicenter retrospective study on patients with neuro-ophthalmic sarcoidosis. Response to therapy was based on visual acuity, visual f...

Full description

Saved in:
Bibliographic Details
Published in:Ocular immunology and inflammation 2022-05, Vol.30 (4), p.821-828
Main Authors: Leclercq, Mathilde, Sené, Thomas, Chapelon-Abric, Catherine, Desbois, Anne Claire, Domont, Fanny, Maillart, Elisabeth, Shor, Natalia, Vignal-Clermont, Catherine, Guéguen, Antoine, Bodaghi, Bahram, Cacoub, Patrice, Touitou, Valerie, Saadoun, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neuro-ophthalmologic manifestations are uncommon in sarcoidosis. We aim to assess the prognostic factors and outcome of neuro-ophthalmic sarcoidosis. We conducted a multicenter retrospective study on patients with neuro-ophthalmic sarcoidosis. Response to therapy was based on visual acuity, visual field, and orbital MRI exam. Factors associated with remission and relapse were analyzed. Thirty-five patients [median (IQR) age of 37 years (26.5-53), 63% of women] were included. The diagnosis of sarcoidosis was concomitant of neuro-ophthalmologic symptoms in 63% of cases. Optic neuritis was the most common manifestation. All patients received corticosteroids and 34% had immunosuppressants. At 6 months, 61% improved, 30% were stable, and 9% worsened. Twenty percent of patients had severe visual deficiency at the end of follow-up. Nonresponders patients had significantly worse visual acuity at baseline (p = 0.01). Relapses were less frequent in patients with retro-bulbar optic neuropathy (p = 0.03). Prognosis of neuro-ophthalmic sarcoidosis is poor.
ISSN:0927-3948
1744-5078
DOI:10.1080/09273948.2020.1834585